(Updated - May 20, 2021 4:23 PM EDT)

UBS analyst Eliana Merle initiates coverage on BridgeBio Pharma (NASDAQ: BBIO) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE